Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AA34893 in Major Depressive Disorder
NCT00766870Phase 2Terminated
- Sponsor
- Lundbeck
- Start
- Sep 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LU AA34893 in major depressive disorder (MDD), sponsored by Lundbeck. Started Sep 2008; status: terminated.
02
Drugs
LU AA34893
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00766870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00766870.